Free Trial

Leap Therapeutics (LPTX) Earnings Date, Estimates & Call Transcripts

Leap Therapeutics logo
$3.74
-0.43 (-10.31%)
(As of 10/31/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 11Estimated
Actual EPS
(Aug. 12)
-$0.52 Missed By -$0.10
Consensus EPS
(Aug. 12)
-$0.42
Skip Charts & View Estimated and Actual Earnings Data

LPTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LPTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Leap Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.58)($0.58)($0.58)
Q2 20241($0.35)($0.35)($0.35)
Q3 20241($0.37)($0.37)($0.37)
Q4 20241($0.31)($0.31)($0.31)
FY 20244($1.61)($1.61)($1.61)
Q1 20251($0.28)($0.28)($0.28)
Q2 20251($0.29)($0.29)($0.29)
Q3 20251($0.31)($0.31)($0.31)
Q4 20251($0.33)($0.33)($0.33)
FY 20254($1.21)($1.21)($1.21)

LPTX Earnings Date and Information

Leap Therapeutics last released its earnings data on August 12th, 2024. The reported ($0.52) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by $0.10. Leap Therapeutics has generated ($2.39) earnings per share over the last year (($2.39) diluted earnings per share). Earnings for Leap Therapeutics are expected to grow in the coming year, from ($1.84) to ($1.36) per share. Leap Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off prior year's report dates.

Leap Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/11/2024
(Estimated)
------- 
8/12/2024Q2 2024($0.42)($0.52)($0.10)($0.52)--
5/13/2024Q1 2024($0.57)($0.51)+$0.06($0.51)--  
3/18/2024Q4 2023($0.56)($0.46)+$0.10($0.46)--  
11/13/2023Q3 2023($0.58)($0.51)+$0.07($0.51)--  
8/14/2023Q2 2023($0.90)($0.91)($0.01)($0.91)--  
5/15/2023Q1 2023($0.90)($3.20)($2.30)($0.32)--  
3/24/2023Q4 2022($0.90)($1.10)($0.20)($0.11)--  
11/14/2022Q3 2022($1.10)($1.30)($0.20)($0.13)--  
8/12/2022Q2 2022($1.00)($1.50)($0.50)($0.15)--  
5/13/2022Q1 2022($1.10)($0.90)+$0.20($0.09)--  
3/11/2022Q4 2021($1.10)($1.00)+$0.10($0.10)$0.38 million$0.38 million  
11/12/2021Q3 2021($1.10)($1.40)($0.30)($0.14)$0.38 million$0.38 million  
8/12/2021Q2 2021($1.20)($1.20)-($0.12)$0.38 million$0.38 million  
5/14/2021Q1 2021($1.10)($1.20)($0.10)($0.12)$0.39 million$0.38 million  
3/11/2021Q4 2020($0.90)($0.90)-($0.09)$0.40 million$0.38 million  
11/12/2020Q3 2020($1.30)($0.90)+$0.40($0.09)$0.37 million$0.38 million  
8/13/2020Q2 2020($1.80)($1.2425)+$0.5575($0.12)-$0.38 million  
5/14/2020Q1 2020($2.40)($5.50)($3.10)($0.55)-$0.38 million  
3/16/2020Q4 2019($3.20)($3.30)($0.10)($0.33)--  
11/14/2019Q3($3.30)($3.30)-($0.33)--  

Leap Therapeutics Earnings - Frequently Asked Questions

When is Leap Therapeutics's earnings date?

Leap Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates. Learn more on LPTX's earnings history.

Did Leap Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Leap Therapeutics (NASDAQ:LPTX) missed the analysts' consensus estimate of ($0.42) by $0.10 with a reported earnings per share (EPS) of ($0.52). Learn more on analysts' earnings estimate vs. LPTX's actual earnings.

How much revenue does Leap Therapeutics generate each year?

Leap Therapeutics (NASDAQ:LPTX) has a recorded annual revenue of $1.50 million.

How much profit does Leap Therapeutics generate each year?

Leap Therapeutics (NASDAQ:LPTX) has a recorded net income of -$81.41 million. LPTX has generated -$2.39 earnings per share over the last four quarters.

What is Leap Therapeutics's EPS forecast for next year?

Leap Therapeutics's earnings are expected to grow from ($1.84) per share to ($1.36) per share in the next year.


`

More Earnings Resources from MarketBeat


This page (NASDAQ:LPTX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners